Results 161 to 170 of about 72,711 (261)

Inhibition of Murine Leukemia Virus Replication by Poly(vinyluracil) and Poly(vinyladenine)

open access: green, 1973
Paula M. Pitha   +3 more
openalex   +1 more source

Methylation pattern of genomic RNA from Moloney murine leukemia virus [PDF]

open access: bronze, 1976
Maurice C. Bondurant   +2 more
openalex   +1 more source

Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19. [PDF]

open access: yesInt J Mol Sci
Kratzer B   +8 more
europepmc   +1 more source

Structure and architecture of immature and mature murine leukemia virus capsids. [PDF]

open access: yesProc Natl Acad Sci U S A, 2018
Qu K   +9 more
europepmc   +1 more source

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

open access: yesCell Proliferation, EarlyView.
CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far   +4 more
wiley   +1 more source

Rescue and Transmission of a Replication-Defective Variant of Moloney Murine Leukemia Virus [PDF]

open access: bronze, 1979
Alan Rein   +4 more
openalex   +1 more source

Type I interferon signalling and interferon‐responsive microglia in health and disease

open access: yesThe FEBS Journal, EarlyView.
Recent insights reveal that type I interferon (IFN‐I) signalling plays critical roles in the nervous system beyond antiviral defence. Dysregulated IFN‐I activity is increasingly linked to neurological dysfunction and neurodegeneration, with microglia as central mediators. This review explores the broader impact of IFN‐I signalling on the nervous system
Jose P. Lopez‐Atalaya   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy